Rituximab for the treatment of glomerulonephritis in hepatitis C associated cryoglobulinaemia

MR Korte, MJ Heerde, Rob de Man, M.G.H. Betjes

Research output: Contribution to journalArticleAcademicpeer-review

12 Citations (Scopus)


Mixed-type cryoglobulins are strongly associated with hepatitis C virus (HCV) infection and may lead to vasculitis with renal involvement. The treatment of this condition is antiviral therapy for HCV, but this may be ineffective or not tolerated because of side effects. Alternative strategies such as immunosuppressive drugs and plasmapheresis are of limited use, especially in patients after liver transplantation (LTx). We describe an LTx patient with cryoglobulinaemia-associated glomerulonephritis, who was treated successfully with the B cell depleting monoclonal antibody rituximab.
Original languageUndefined/Unknown
Pages (from-to)27-30
Number of pages4
JournalNetherlands Journal of Medicine
Issue number1
Publication statusPublished - 2008

Cite this